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1. Introduction 
‘I%e in vivo action of growth hormone (somato- 
tropin) is presumed to be mediated by polypeptides, 
the so called somatomedins, noncovalently bound to 
carrier proteins found in plasma [1,2] . During the 
isolation of sulfation factor, or somatomedin A, frac- 
tions were also examined for stim~ation of DNA 
synthesis in glial cells in culture. A different type of 
activity to the sulfation factor, which also appeared 
to be growth hormone-dependent was found [3]. 
This was termed somatomedin B (SM-B) [4] , later 
isolated and purified to homogeneity [5] and shown 
to be a protein;mol. wt 5000, cross-linked by four 
disulfide bridges with N-terminal aspartic acid. Four 
rather similar components were found, differing by 
electrophoretic mobility. It is possible that compo- 
nents 3 and 4 are homologues; the amino acid compo- 
sition suggests a slight difference in certain residues. 
Antiserum developed to the impure compound [6] 
and later here with the pure protein showed a relation- 
ship to growth hormone status. Serum levels were 
found to be higher in acromegaly, and in pituitary 
dwarfs at the lower level of the normal range [7] . 
High levels were also found at delivery and during 
oestrogen treatment [8] . The primary structure has 
been determined and shows that SM-B is not only 
related structurally to small trypsin inhibitors, but 
also has an ‘active site’ region, and inhibits trypsin, 
but not plasmin, thrombin or kallikrein. 
2. Mate&i and methods 
2.1. ~om~~ornedi~ B 
This was isolated from human plasma nd corre- 
sponds to fraction 1 [5]. The reduced and alkylated 
derivative (RCM) was prepared essentially as in [9]. 
Iodo [ “C]acetic acid (New England Nuclear).was 
used essentially as in [lo] to allow for ready localiza- 
tion of peptides. 
2.2. Enzymatic digestions 
These were performed on the RCM derivative 
essentially as in f 111 using the following enzymes: 
trypsin (Worthington), chymotrypsin (Worthington), 
carboxypeptidase A (Worthington), carboxypeptidase 
B (Wo~h~gton), and staphylococcal protease II [ 121 
(personal gift). 
The staphyloccal protease digestion was performed 
in 0.1 M NH4HCOa at an enzyme/substrate ratio of 
1: 100, at room temperature for 24 h, followed by an 
immediate gel fntration in acid medium. 
2.3. Separation of peptides 
This was performed essentially as in [ 1 l] : an initial 
gel filtration on Sephadex G-25 (1 X 140 cm) in 
0.02 N HCl; fractions were read spectrophotomet~- 
tally at 230 nm, at 570 nm (ninhydrin) after alkaline 
hydrolysis, or else by radioactivity in aliquots mea- 
sured in a liquid scintillation counter. The subsequent 
stage was usually column electrophoresis on cellulose, 
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at pH 5.0, in 0.05 M pyridine acetate buffer (column 
size 1 X 100 cm or 0.75 X 50 cm [ll]). 
2.4. Analysis of peptides 
2.4.1. Amino acid analysis 
Peptide, < lb nmol, was hydrolyzed in 6 N HCl 
and analyzed on a Durrum D-500 analyzer by Dr D. 
Eaker, Institute of Biochemistry, Uppsala. 
2.4.2. Edman degradation 
This was performed in principle according to the 
direct Edman technique as in [ 11 ,131 with the 
modifications: 
(i) The number of benzene washes was reduced to 
two or less. 
(ii) The thin-layer chromatography was performed 
on 10 X 10 cm plates instead of 20 X 20 cm. 
This allowed shorter running times, sharper spots and 
greater sensitivity. 
3. Results 
The amino acid composition of the native sub- 
stance and the relevant peptides are shown in table 1. 
Chromatographic and electrophoretic peptide 
separations are shown in fig. 1,2. Figure 1 shows the 
separation of tryptic peptides by gel filtration on 
Sephadex G-25; fraction 1 was further separated by 
column electrophoresis into 2 main components, 
yielding the peptide Tryp-1 . Figure 2 shows the 
separation of peptides from the digestion with S- 
protease, fractions B and C from gel filtration could 
be further separated by electrophoresis. The chymo- 
tryptic peptides were also separated in a similar 
manner, Chy-2 was obtained pure from the gel filtra- 
tion while Chy-1 was obtained from additional 
electrophoresis. As can be seen from table 1, all 
amino acid compositions are close to integral values 
and indicate homogeneity. 
Edman degradation of the intact RCM derivative 
identified residues l-l 6, and placed the unique Phe 
at position 13 and one of the two Val residues at 
position 15 (Bg.1). Carboxypeptidase A digest of 
this same material gave Val-Thr as residues 43-44. 
No further amino acids were released with carboxy- 
peptidase B. Tryptic digestion gave a peptide of 26 
ammo acids (Tryp-1) containing 6 residues of cys- 
teine, one Val and one Pro, suggesting that this was 
the carboxyl terminal, residues 19-44, and that 
Table 1 
Somatomedin B - peptides 
Residue SM-B Tryp-1 
19-44 
SP-1 
12-23 
SP-2 
24-38 
SP-3 
39-44 
Chy-1 
29-35 
Chy-2 
36-44 
ASP 
Thr 
Ser 
Glu 
Pro 
GUY 
Ala 
CYS 
Val 
Leu 
W 
Phe 
LYS 
A% 
Total 44 26 12 17 6 7 9 
5.23 5 2.04 2 2.99 3 2.80 3 - 1.00 1 - 
3.96 4 3.77 3 - 2.35 2 1.02 1 1.02 1 2.06 2 
3.09 3 2.08 2 - 2.16 2 - 0.93 1 - 
8.12 8 5.02 5 2.19 2 2.05 2 1.06 1 1.12 1 2.25 2 
0.77 1 1.06 1 - - 0.92 1 - 1.00 1 
2.07 2 - 1.04 1 - _ - _ 
1.06 1 1.62 1 - 1.12 1 - - 0.99 1 
8.00 8 5.50 6 1.74 2 3.20 3 0.96 1 1.75 2 0.87 1 
1.83 2 0.97 1 0.95 1 - 1.00 1 - 0.96 1 
0.95 1 1.03 1 - 1.02 1 - _ - 
2.90 3 2.53 3 - - _ 1.15 1 - 
0.99 1 - 0.93 1 3.12 3 - - _ 
3.83 4 0.98 1 1.99 2 - 1.14 1 - 1.01 1 
1.27 1 - - _ _ _ - 
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Fig.1. Separation by gel filtration of tryptic peptides (from 
100 nmol, 500 pg protein) on Sephadex G-25 (1 X 140 cm) in 
0.02 N HCl(2.3 ml fractions). Fraction 1 separated by cellu- 
lose column electrophoresis (1 X 99 cm), pH 5.0 (0.05 M 
pyridine acetate), 18 h, 9.8 mA, 1000 V, migration towards 
the anode. Fractions, 1 ml, collected. 
residue 18 was probably Lys and that a Lys-Pro 
sequence was present. Nine stages of degradation on 
this peptide gave residues 19-27 and placed the single 
Leu at position 24. Digestion with the staphylococcal 
protease, which splits specifically on the carboxyl 
side of glutamic acid, gave 5 peptides, identified from 
the above, and by amino acid compositions, as resi- 
dues l-3,4-11,12-23(SP-1),24-38(SP-2),3944 
(SP-3). Edman degradation on SP-I was performed 
through 11 stages and free Glu (determined by amino 
acid analysis) at residue 23 and the overlap 18-19 
were confirmed. SP-2 was degraded 11 stages to 
Cys 34, and with carboxypeptidase A the sequence 
35-38 was obtained. Edman degradation of SP-3 
for 5 stages allowed the identification of free Thr 
(by amino acid analysis) at residue 44. The chymo- 
tryptic digest gave 2 peptides relevant here, 29-35 
(Chy-1) and 36-44 (Chy-2), providing confirmation 
of the Tyr at residue 3.5, the overlap 35-36 and the 
sequence 36-38 by Edman degradation. All of the 
44 residues in somatomedin B have therefore been 
accounted for and the primary structure is shown in 
tig.3. 
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Fig.2. Separation by gel filtration of staphylococcal protease 
peptides (from 100 nmol, 500 pg protein) on Sephadex G-25 
(1 x 140 cm) in 0.02 N HCI (2.3 ml fractions). Fraction B 
separated by cellulose column electrophoresis (1 X 96 cm) 
for 15 h, 9 mA and 1000 V, in 0.05 M pyridine acetate, 
migration towards the anode. Fractions, 1 ml, collected. 
Fraction C separated under identical conditions. 
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123456789 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
Asp-Gln-Glu-Ser-Cys-Lys-Gly-Arg-Cys-Thr-Glu-Gly-Phe-Asn-Val-Asp-Lys-Lys-Cys-Gln-Cys-Asp-Glu- 
< 
Tryp-1 
24 25 26 27 20 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 
Leu-Cys-Ser-Tyr-Tyr-GIn-Ser-Asn-Cys-Thr-Cys-Tyr-Thr-Ala-Glu-Cys-Lys-Pro-Gln-Val-Thr- OH 
< 
SP-2 SP-3 z 
i Chy-1 - 4 Chy-2 z 
Tryp-1 
Fig.3. Complete primary structure of somatomedin B. 
Results ‘SEARCH’ 
The total number of sequences searched = 1003 
The total number of segments of length 25 compared to the test piece = 83941 
The constant 2 has been added to the mutation data 1976 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
The test piece DQESCKGRCTEG FNVDKKCQCDELC 
Score Beg. End n 
1 96 14 38 
2 93 13 37 
3 89 6 30 
4 88 4 28 
5 88 100 124 
6 87 10 34 
7 79 10 34 
S S K P C (C.B) H (C.A.C) T K.S I PPQCR 
EQGPCKGRI PRYFYNPASRM 
TPDVTSQICADGHVCYTKTW 
SSKPCCDQCACTKSNPPQCR 
VHDCCYGKIYWWFPFAKNCQ 
SSKPCCDLCMCTASMPPQCH 
The test piece 
1 Protease inhibitor - lima bean 
2 Protease inhibitor - red sea turtle (fragment) 
3 Long neurotoxin 2 - forest cobra 
4 Protease inhibitor (Bowman-Birk) - soybean 
5 Phospholipase A2 - mamushi 
6 Protease inhibitor C-II - soybean 
7 Basic trypsin inhibitor (bovine) 
Fig.4. Computer alignment of 1st 25 residues of somatomedin B with other sequences. 
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4. Discussion 
The primary structure of somatomedin B shows it 
to be a unique protein not obviously related to insulin 
or any of the other known growth factors. The 3 
tyrosine residues are clustered in the latter third of 
the molecule, while 4 of the ilve basic amino acids 
are present within the first 18 residues; a Lys-Lys 
sequence being found at residue 17-l 8. Of the 
13 glutamic and aspartic acid residues, 6 are amidated, 
resulting in a net negative charge of 2. A computer 
sequence search of the first 25 residues performed 
[ 141 (Program SEARCH) suggested a close relation- 
ship to protease inhibitors and phospholipases. The 
alignments are shown in iig.4. A closer examination 
of the N-terminal sequence of SM-B revealed in 
residues 5-8 (Cys-Lys-Gly-Arg) a stretch of 
sequence almost identical to that found in the basic 
bovine trypsin inhibitor [ 151, residues 14-17 (Cys- 
Lys-Ala-Arg), where the Lys-Ala peptide bond is 
the cleavage site for trypsin. During our attempts to 
determine the disulfide pairing of SM-B, we observed 
that the native molecule was extremely resistant to 
cleavage by proteolytic enzymes. The protease inhibi- 
tory activity of somatomedin B was tested using the 
chromogenic peptide substrates [ 16,171 for trypsin, 
plasmin, kallikrein and thrombin. Only trypsin was 
specifically inhibited [ 181. When iodinated by the 
lactoperoxidase method SM-B bound poorly or not 
at all to most membranes [ 191 except testis. Perhaps 
the proximity of the tyrosine residues means that 
addition of the large iodine molecule in some way 
hinders binding, or else no specific binding site exists. 
Iodination does not prevent measurement by radio- 
immunoassay, but the iodinated protein does not 
appear to recombine with its carrier protein [7] . 
Radioimmunoassay measurements in serum show a 
gradual decline in levels with age, a positive correla- 
tion with overproduction of GH [20] and during 
oestrogen treatment [8] . A rise is seen during preg 
nancy which reaches a maximum at delivery. In vivo 
studies on hypophysectomized rats studying mem- 
brane transport of amino acids as an indirect measure 
of protein synthesis show that the steady-state level 
in blood serum of the non-metabolizable amino acid, 
o-aminoisobutyric acid, is decreased, concomitant 
with a decrease in blood sugar [21] . 
Up to now the role and function of somatomedin 
B have been somewhat enigmatic. A growth hormone- 
dependent trypsin-like protease inhibitor could have 
effects on controlled proteolysis during conversion of 
prohormones, or on the action of the ‘true’ somato- 
medins, for example, the regulation of receptor func- 
tions or membrane transport. We know that someto- 
medin B does not compete in the radioreceptor assay 
for SM-A [22] , or have activity on chick fibroblasts 
or adipocytes [23] but the protein has not been tested 
in combination with any other somatomedins or 
growth factors. Eventual activity in the serum carrier 
protein for somatomedin B has not been investigated. 
Further experiments on the biological role of SM-B 
and its carrier protein are in progress. 
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